Utilizing shared decision-making in the diagnosis and management of hypertrophic cardiomyopathy can support positive outcomes for patients, family members and caregivers. Guests Kim Hecker, BSN, BA, RN, and Jillian Thorne, describe the process, and the impacts across all stages of the patient journey.

References and related resources:

2024 AHA/ACC Guideline for the Management of HCM

Twice the Heart Foundation: https://www.instagram.com/twicetheheartfoundation/

PCNA resources on HCM for providers and patients

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Review the latest clinical guidelines on LDL-C reduction, especially for your patients with diabetes. Guest Susan Halli Demeter, DNP, CNP, NP, also reflects on how engaging patients in shared decision-making aids in treatment adherence and identifies potential barriers to address, including polypharmacy, access, and other issues.

References and Related Resources:

PCNA Lipid resources for providers and patients

PCNA Diabetes resources for providers and patients

CARDS trial

IMPROVE-IT trial

FOURIER trial

ODYSSEY trial

VESALIUS-CV trial

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Earlier ASCVD risk reduction is better--particularly for patients with diabetes. Guest Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, discusses the importance of reviewing family history, and shares strategies for decision-making in primary and secondary risk reduction strategies asuch as lowering LDL-C, blood glucose, hypertension, smoking, and other factors.

Related Resources:

PCNA Lipid resources for providers and patients

PCNA Diabetes resources for providers and patients

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

PREVENT Risk Calculator

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.